Fulgent Genetics Inc (FLGT)

$16.82 +0.38 (2.31%)
Market Cap 500.34M
Revenue (ttm) 322.67M
Net Income (ttm) -60.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.75%
Debt to Equity Ratio 0.00
Volume 556,200
Avg Vol 559,552
Day's Range N/A - N/A
Shares Out 29.75M
Stochastic %K 93%
Beta 0.89
Analysts Sell
Price Target $24.33

Company Profile

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer serv...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 626 350 0537
Fax: 626 454 1667
Address:
4399 Santa Anita Avenue, El Monte, United States
TechridyStocks
TechridyStocks Apr. 3 at 11:12 PM
$FLGT .47 book value 👀👀 I’m in now.
0 · Reply
Sexydream
Sexydream Apr. 2 at 5:42 AM
$FLGT realistically, what's everyone's sell target price? I think if it hits 30 I'm out.
1 · Reply
Endergast07
Endergast07 Apr. 1 at 1:30 AM
$FLGT Around 2 MIO shares bought back by FLGT in the first quarter, if I read a sec filing correctly
0 · Reply
boredmember
boredmember Mar. 24 at 3:29 PM
$FLGT extremely strong on this down day
0 · Reply
jf152
jf152 Mar. 24 at 2:38 PM
$FLGT Good read here: https://seekingalpha.com/article/4881551-fulgent-genetics-a-major-market-misconception
0 · Reply
jf152
jf152 Mar. 23 at 10:25 PM
$FLGT it looks like the shorts were hoping the acquisition were be in quarter 2 and they would have another three months of easy manipulation. Screw them. They are evil anyway.
0 · Reply
prismmarketview
prismmarketview Mar. 18 at 2:14 PM
Fulgent Genetics (NASDAQ: $FLGT) has closed its roughly $57M “dual” deal to buy Bako Diagnostics assets and all of StrataDx, doubling its pathology sales force and expanding into podiatry and dermatopathology as it builds a nationwide AI‑enabled diagnostic lab platform. https://prismmarketview.com/fulgent-genetics-closes-dual-pathology-deal/
0 · Reply
Endergast07
Endergast07 Mar. 17 at 10:25 PM
$FLGT Still a lot of volume, so many days after earnings, interesting...
1 · Reply
boredmember
boredmember Mar. 17 at 2:19 PM
$FLGT near term easy $20-22
0 · Reply
BenGang
BenGang Mar. 13 at 4:42 PM
$FLGT reversal perhaps? Watching it
0 · Reply
Latest News on FLGT
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

Mar 17, 2026, 4:31 PM EDT - 18 days ago

Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm

Mar 13, 2026, 9:00 AM EDT - 23 days ago

Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

Mar 12, 2026, 2:06 PM EDT - 23 days ago

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

Fulgent Genetics: A Major Market Misconception

Mar 12, 2026, 9:11 AM EDT - 24 days ago

Fulgent Genetics: A Major Market Misconception

Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript

Feb 27, 2026, 6:07 PM EST - 5 weeks ago

Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript

Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 27, 2026, 7:00 AM EST - 5 weeks ago

Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

Feb 12, 2026, 7:30 AM EST - 7 weeks ago

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock

Jan 27, 2026, 3:59 AM EST - 2 months ago

Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Dec 22, 2025, 4:10 PM EST - 3 months ago

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 11, 2025, 9:04 AM EST - 5 months ago

Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript

Fulgent to Participate in Upcoming Conferences

Nov 7, 2025, 4:05 PM EST - 5 months ago

Fulgent to Participate in Upcoming Conferences

Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 2:56 PM EST - 5 months ago

Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

Fulgent Reports Third Quarter 2025 Financial Results

Nov 7, 2025, 7:05 AM EST - 5 months ago

Fulgent Reports Third Quarter 2025 Financial Results

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Oct 20, 2025, 6:00 AM EDT - 5 months ago

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Oct 16, 2025, 7:00 AM EDT - 6 months ago

Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

Sep 8, 2025, 1:58 PM EDT - 7 months ago

Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 12:28 PM EDT - 8 months ago

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Reports Second Quarter 2025 Financial Results

Aug 1, 2025, 7:00 AM EDT - 8 months ago

Fulgent Reports Second Quarter 2025 Financial Results

Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Jul 17, 2025, 7:00 AM EDT - 9 months ago

Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Jul 10, 2025, 4:05 PM EDT - 9 months ago

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out

Jun 10, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation

Jun 9, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 10 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation

Jun 6, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect

Jun 5, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation

Jun 4, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 2, 2025, 10:00 AM EDT - 10 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

May 30, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 29, 2025, 10:00 AM EDT - 11 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

May 28, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

May 27, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

May 24, 2025, 9:19 PM EDT - 11 months ago

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

May 19, 2025, 8:11 AM EDT - 11 months ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

May 2, 2025, 12:27 PM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

Fulgent Reports First Quarter 2025 Financial Results

May 2, 2025, 7:00 AM EDT - 1 year ago

Fulgent Reports First Quarter 2025 Financial Results

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Apr 10, 2025, 4:05 PM EDT - 1 year ago

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Stock Picks From Seeking Alpha's March 2025 New Analysts

Apr 4, 2025, 2:30 PM EDT - 1 year ago

Stock Picks From Seeking Alpha's March 2025 New Analysts

AI ARGX CCL CEPU CF CROX CUK

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Mar 20, 2025, 5:46 AM EDT - 1 year ago

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 11:57 AM EST - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 28, 2025, 7:00 AM EST - 1 year ago

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Feb 6, 2025, 4:05 PM EST - 1 year ago

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

TechridyStocks
TechridyStocks Apr. 3 at 11:12 PM
$FLGT .47 book value 👀👀 I’m in now.
0 · Reply
Sexydream
Sexydream Apr. 2 at 5:42 AM
$FLGT realistically, what's everyone's sell target price? I think if it hits 30 I'm out.
1 · Reply
Endergast07
Endergast07 Apr. 1 at 1:30 AM
$FLGT Around 2 MIO shares bought back by FLGT in the first quarter, if I read a sec filing correctly
0 · Reply
boredmember
boredmember Mar. 24 at 3:29 PM
$FLGT extremely strong on this down day
0 · Reply
jf152
jf152 Mar. 24 at 2:38 PM
$FLGT Good read here: https://seekingalpha.com/article/4881551-fulgent-genetics-a-major-market-misconception
0 · Reply
jf152
jf152 Mar. 23 at 10:25 PM
$FLGT it looks like the shorts were hoping the acquisition were be in quarter 2 and they would have another three months of easy manipulation. Screw them. They are evil anyway.
0 · Reply
prismmarketview
prismmarketview Mar. 18 at 2:14 PM
Fulgent Genetics (NASDAQ: $FLGT) has closed its roughly $57M “dual” deal to buy Bako Diagnostics assets and all of StrataDx, doubling its pathology sales force and expanding into podiatry and dermatopathology as it builds a nationwide AI‑enabled diagnostic lab platform. https://prismmarketview.com/fulgent-genetics-closes-dual-pathology-deal/
0 · Reply
Endergast07
Endergast07 Mar. 17 at 10:25 PM
$FLGT Still a lot of volume, so many days after earnings, interesting...
1 · Reply
boredmember
boredmember Mar. 17 at 2:19 PM
$FLGT near term easy $20-22
0 · Reply
BenGang
BenGang Mar. 13 at 4:42 PM
$FLGT reversal perhaps? Watching it
0 · Reply
Endergast07
Endergast07 Mar. 11 at 10:28 PM
$FLGT Read the latest SEC form 4 to know who is loading up :)
1 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 10 at 7:25 PM
$FLGT one hour ago — Raising target price to $18.00. FULGENT GENETICS INC has an Investment Rating of HOLD; a target price of $18.000000
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 10 at 6:23 PM
$FLGT new TP 18-24$ but no rebound yet Funck
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 10 at 4:18 PM
$FLGT third attempts to break 15,5 Wait
0 · Reply
Lowkeyoptions
Lowkeyoptions Mar. 10 at 2:16 PM
$FLGT about time this starts moving back
0 · Reply
jf152
jf152 Mar. 9 at 8:39 PM
$FLGT Weird sudden price movement from 3:20-3:40.
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 9 at 7:16 PM
$FLGT I bought more .. in my opinion 20-22 $ very next
0 · Reply
Streetdilly1
Streetdilly1 Mar. 8 at 12:11 AM
$FLGT Fulgent Genetics (FLGT) has an active $250 million share repurchase program initiated in March 2022 to return capital, with over $108 million in shares repurchased as of mid-2025. As of late 2025, approximately $139.6 million remained available for further buybacks, with the company maintaining a strong, debt-free cash position
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 6 at 5:44 PM
$FLGT zero volumes and easy down for rottens
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 6 at 4:02 PM
$FLGT …
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 6 at 3:51 PM
$FLGT here we are next 15,33
0 · Reply
Bobfree
Bobfree Mar. 6 at 3:17 PM
$FLGT If management was smart and did substantial buyback already here at bottom going to have to increase PT significantly. This post earnings SP drop may turn out to be one of the best things to have ever happened to this company.
0 · Reply